AKT1 and melanoma: This strategy could be similarly used for melanoma given the expression of TSHR induced by suppressing the MAPK and PI3K/Akt pathways and the enhancement of expression of other iodide-metabolizing genes by TSH in melanoma cells demonstrated in the present study.